Pure Harvest Cannabis Group Inc

PINK:PHCG USA Drug Manufacturers - Specialty & Generic
Market Cap
$538.54K
Market Cap Rank
#39557 Global
#12884 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$1.00
About

Pure Harvest Corporate Group, Inc. focuses on the acquisition and operation of licensed medical and recreational marijuana dispensaries, cultivation facilities, and production facilities. It also focuses on providing cannabis and hemp-derived health and wellness products; and applying education, research and development, and technology to various sectors. The company was formerly known as Pure Ha… Read more

Pure Harvest Cannabis Group Inc (PHCG) - Net Assets

Latest net assets as of June 2025: $-2.75 Million USD

Based on the latest financial reports, Pure Harvest Cannabis Group Inc (PHCG) has net assets worth $-2.75 Million USD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.61K) and total liabilities ($2.76 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-2.75 Million
% of Total Assets -170777.12%
Annual Growth Rate N/A
5-Year Change -343.38%
10-Year Change N/A
Growth Volatility 84.01

Pure Harvest Cannabis Group Inc - Net Assets Trend (2015–2024)

This chart illustrates how Pure Harvest Cannabis Group Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Pure Harvest Cannabis Group Inc (2015–2024)

The table below shows the annual net assets of Pure Harvest Cannabis Group Inc from 2015 to 2024.

Year Net Assets Change
2024-12-31 $-8.23 Million -634.46%
2022-12-31 $-1.12 Million +3.32%
2021-12-31 $-1.16 Million -128.84%
2020-12-31 $4.02 Million +18.84%
2019-12-31 $3.38 Million +2557.92%
2018-12-31 $-137.62K +32.91%
2017-12-31 $-205.12K -195.25%
2016-12-31 $215.35K -26.82%
2015-12-31 $294.26K --

Equity Component Analysis

This analysis shows how different components contribute to Pure Harvest Cannabis Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 3043017200.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $1.53 Million %
Other Components $20.95 Million %
Total Equity $-8.23 Million 100.00%

Pure Harvest Cannabis Group Inc Competitors by Market Cap

The table below lists competitors of Pure Harvest Cannabis Group Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Pure Harvest Cannabis Group Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2024, total equity changed from -1,120,892 to -8,232,485, a change of -7,111,593.
  • Net loss of 709,000 reduced equity.
  • Other comprehensive income decreased equity by 2,500.
  • Other factors decreased equity by 6,400,093.

Equity Change Factors (2022 to 2024)

Factor Impact Contribution
Net Income $-709.00K -8.61%
Other Comprehensive Income $-2.50K -0.03%
Other Changes $-6.40 Million -77.74%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Pure Harvest Cannabis Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2015-12-31 $0.02 $0.00 x
2016-12-31 $0.02 $0.00 x
2017-12-31 $-0.01 $0.00 x
2018-12-31 $-0.01 $0.00 x
2019-12-31 $0.10 $0.00 x
2020-12-31 $0.08 $0.00 x
2021-12-31 $-0.02 $0.00 x
2022-12-31 $-0.01 $0.00 x
2024-12-31 $-0.06 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Pure Harvest Cannabis Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-27.39%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 -18.42% -53.92% 0.34x 1.01x $-83.64K
2016 -36.64% -96.36% 0.37x 1.02x $-100.45K
2017 0.00% 0.00% 0.00x 0.00x $-184.63K
2018 0.00% 0.00% 0.00x 0.00x $-32.41K
2019 -33.55% -2943.88% 0.01x 1.42x $-1.47 Million
2020 -157.89% -862.73% 0.07x 2.75x $-6.75 Million
2021 0.00% -551.10% 0.29x 0.00x $-13.87 Million
2022 0.00% -127.14% 0.14x 0.00x $-1.54 Million
2024 0.00% 0.00% 0.00x 0.00x $114.25K

Industry Comparison

This section compares Pure Harvest Cannabis Group Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $439,452,927
  • Average return on equity (ROE) among peers: -31.68%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Pure Harvest Cannabis Group Inc (PHCG) $-2.75 Million -18.42% N/A $190.39K
Ascend Wellness Holdings Inc (AAWH) $71.80 Million -118.37% 11.54x $48.90 Million
AB Science S.A (ABSCF) $-21.01 Million 0.00% 0.00x $39.89 Million
Alterola Biotech Inc (ABTI) $-294.68K 0.00% 0.00x $603.58K
Aurora Cannabis Inc (ACB) $521.74 Million -156.52% 0.78x $195.20 Million
Acreage Holdings Inc (ACRDF) $494.79 Million -30.37% 0.40x $13.48K
Acura Pharmaceuticals Inc (ACUR) $29.91 Million 0.00% 0.07x $13.20K
Agra Ventures Ltd. (AGFAF) $1.72 Million -18.78% 0.11x $298.23K
Allergy Therapeutics plc (AGYTF) $20.08 Million -10.91% 0.33x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $21.19 Million 12.93% 1.96x $1.85
Adcock Ingram Holdings Limited (AIHLF) $3.25 Billion 5.19% 0.72x $85.61 Million